Carmat - Implantation momentum
Carmat recently announced that it has implanted nine of its physiologic heart replacement therapies (PHRT) since July, six of which were commercial...
1.4k Views
Video: Carmat - executive interview with Stéphane Piat
Carmat is French biotech company that has created the first auto-regulating, bioprosthetic artificial heart able to mimic the natural physiology of...
696 Views
Carmat - Full-year results and clinical updates
In January, Carmat announced data from the initial 10 patients included in the first leg of its EU pivotal study investigating the surgical...
782 Views
Carmat - First half of CE mark-enabling trial fully enrolled
In July, Carmat announced the enrolment of the 10th and final patient included in the first leg of its EU pivotal study investigating the surgical...
47 Views
Carmat - Carmat raises €52.9m and extends cash runway
Carmat raised €52.9m through the sale of 2.645m shares at €20.0 per share. We estimate that this should increase the firm’s cash runway into Q219,...
86 Views
No more insights